Three (4%) patients harbored MYC and BCL6 rearrangements, while none exhibited high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements. This evidence concerns the gene MYC and B-cell non-Hodgkin lymphoma.